0001127602-24-020165.txt : 20240705
0001127602-24-020165.hdr.sgml : 20240705
20240705160254
ACCESSION NUMBER: 0001127602-24-020165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240705
DATE AS OF CHANGE: 20240705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coen Steven P.
CENTRAL INDEX KEY: 0001977441
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 241102621
MAIL ADDRESS:
STREET 1: C/O GINKGO BIOWORKS HOLDINGS, INC.
STREET 2: 27 DRYDOCK AVENUE, 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-07-01
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001977441
Coen Steven P.
C/O GINKGO BIOWORKS HOLDINGS, INC.
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
See remarks
0
Class A Common Stock
2024-07-01
4
M
0
23496
A
202328
D
Class A Common Stock
2024-07-01
4
M
0
6250
A
208578
D
Class A Common Stock
2024-07-02
4
S
0
13520
.326
D
195058
D
Restricted Stock Units
2024-07-01
4
M
0
23496
D
Class A Common Stock
23496
798873
D
Restricted Stock Units
2024-07-01
4
M
0
6250
D
Class A Common Stock
6250
275001
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the
vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover"
transaction.
The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
Chief Accounting Officer
/s/ Karen Tepichin, Attorney-in-Fact
2024-07-05